https://www.selleckchem.com/pr....oducts/relacorilant.
Twenty MS-ICUs reached at least the 75th percentile at the end of the study in comparison with the same number who remain within the 25th percentile (score, 76.1 ± 7.5 vs 28.0 ± 7.3; P .0001). Several indicators performed better in the MS-ICUs in the 75th versus 25th percentiles antimicrobial consumption (143.4 vs 159.4 DDD per 100 patient days; P .0001), adherence to clinical guidelines (92.5% vs 59.3%; P .0001), validation of prescription by pharmacist (72.0% vs 58.0%; P .0001), crude mortality (15.9% vs 17.7%
Curtir
Comentario
Compartilhar
